Amphastar Pharmaceuticals Depreciation & Amortization 2011-2026 | AMPH

Annual Depreciation & Amortization Amphastar Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31.6 M	28.2 M	25.2 M	23.8 M	10.2 M	9.03 M	7.06 M	6.05 M	6.42 M	12.2 M	11.3 M	12.5 M	11.2 M	9.66 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
31.6 M	6.05 M	14.6 M

Quarterly Depreciation & Amortization Amphastar Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
14.1 M	14.6 M	7.37 M	-	13.4 M	13.1 M	6.82 M	-	9.62 M	3.06 M	3.4 M	-	3.42 M	3 M	2.74 M	-	2.5 M	2.64 M	2.48 M	-	2.46 M	2.03 M	2.05 M	-	1.7 M	1.66 M	1.64 M	-	10.4 M	6.51 M	3.06 M	-	9.67 M	6.24 M	3.1 M	-	9.01 M	6 M	2.95 M	-	8.52 M	5.63 M	2.77 M	-	9.24 M	6.04 M	2.94 M	-	8.19 M	5.4 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
14.6 M	1.64 M	5.78 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Precigen PGEN	3.2 M	$ 3.1	-0.96 %	$ 758 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	7.55 M	$ 1.33	0.76 %	$ 339 M	Britain
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
Corbus Pharmaceuticals Holdings CRBP	233 K	$ 8.31	1.59 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 47.09	1.42 %	$ 4.23 B	Schweiz
Arbutus Biopharma Corporation ABUS	363 K	$ 4.53	5.1 %	$ 868 M	Canada
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
CytomX Therapeutics CTMX	1.2 M	$ 4.22	-0.47 %	$ 582 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Cyclacel Pharmaceuticals CYCC	6 K	-	-5.98 %	$ 34.1 M	USA